Elevance Health, Inc.
ELV
$376.63
$13.893.83%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.75% | 12.00% | 13.53% | 16.24% | 14.70% |
| Total Other Revenue | 13.19% | -1.21% | 6.55% | 3.85% | 15.55% |
| Total Revenue | 2.64% | 9.48% | 12.33% | 14.04% | 14.83% |
| Cost of Revenue | 0.86% | 13.63% | 15.75% | 20.06% | 15.60% |
| Gross Profit | 7.27% | -2.17% | 3.07% | -0.03% | 12.87% |
| SG&A Expenses | 14.68% | 2.34% | 9.86% | 4.09% | 18.05% |
| Depreciation & Amortization | -27.74% | -8.89% | 32.79% | -9.26% | 33.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.87% | 10.85% | 14.47% | 16.06% | 16.20% |
| Operating Income | -15.28% | -38.96% | -26.11% | -12.99% | -1.97% |
| Income Before Tax | -17.63% | -64.52% | 2.40% | -23.24% | -4.83% |
| Income Tax Expenses | -11.26% | -271.50% | -40.00% | -20.00% | -11.16% |
| Earnings from Continuing Operations | -19.41% | 32.20% | 17.76% | -24.21% | -2.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 500.00% | -80.00% | -75.00% | 0.00% | 66.67% |
| Net Income | -19.19% | 30.86% | 17.03% | -24.22% | -2.80% |
| EBIT | -15.28% | -38.96% | -26.11% | -12.99% | -1.97% |
| EBITDA | -14.20% | -29.10% | -20.80% | -10.35% | -0.59% |
| EPS Basic | -16.77% | 36.35% | 21.54% | -21.86% | -0.10% |
| Normalized Basic EPS | -14.87% | -54.78% | -30.01% | -13.95% | -2.08% |
| EPS Diluted | -16.75% | 36.35% | 22.02% | -21.62% | 0.21% |
| Normalized Diluted EPS | -14.80% | -54.78% | -29.77% | -13.73% | -1.80% |
| Average Basic Shares Outstanding | -2.92% | -4.02% | -3.71% | -3.01% | -2.71% |
| Average Diluted Shares Outstanding | -2.99% | -4.02% | -4.03% | -3.26% | -2.99% |
| Dividend Per Share | 0.58% | 4.91% | 4.91% | 4.91% | 4.91% |
| Payout Ratio | 0.21% | -0.23% | -0.14% | 0.34% | 0.05% |